25-Hydroxyvitamin D levels are associated with mortality and cardiovascular events in systemic lupus erythematosus
Annals of the Rheumatic Diseases · 2025
DOI: 10.1016/j.ard.2025.10.013 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of the Rheumatic Diseases, 2025. Verfasst von Theerada Assawasaksakul und 4 weiteren Autor:innen. Beteiligte Einrichtung: Johns Hopkins University, Baltimore, MD, USA. Electronic address: theerada.azza@gmail.com. Hauptthemen laut MEDLINE: Vitamin D, Lupus Erythematosus, Systemic, Cardiovascular Diseases, Vitamin D Deficiency. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAMS NIH HHS, NIDDK NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
OBJECTIVES: We assessed the association between 25-hydroxyvitamin D (25(OH)D) levels and rates of mortality and cardiovascular events (stroke, myocardial infarction, angina/bypass) in patients with systemic lupus erythematosus (SLE). METHODS: The Hopkins Lupus Cohort began measuring 25(OH)D quarterly in 2009. We examined associations between 25(OH)D levels-baseline, mean in the last year, and most recent values-and both mortality and cardiovascular events (stroke, myocardial infarction, angina/bypass). Two analyses were conducted: (i) a prospective analysis of events occurring after the first 25(OH)D measurement, and (ii) a lifetime analysis including events before cohort entry. All models adjusted for age, sex (female or male), race, and body mass index. RESULTS: The prospective analysis included 11,302 person-years from 1768 patients. Patients with 25(OH)D
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Johns Hopkins University, Baltimore, MD, USA. Electronic address: theerada.azza@gmail.com.
- Johns Hopkins University, Baltimore, MD, USA.
- University of Maryland, Baltimore, MD, USA.
Förderung
- NIAMS NIH HHS
- NIDDK NIH HHS
- National Institutes of Health
Zitieren
APA
Assawasaksakul, T., Fava, A., Goldman, D., Magder, L. S., & Petri, M. (2025). 25-Hydroxyvitamin D levels are associated with mortality and cardiovascular events in systemic lupus erythematosus. Annals of the Rheumatic Diseases. https://doi.org/10.1016/j.ard.2025.10.013
Vancouver
Assawasaksakul T, Fava A, Goldman D, Magder LS, Petri M. 25-Hydroxyvitamin D levels are associated with mortality and cardiovascular events in systemic lupus erythematosus. Annals of the Rheumatic Diseases. 2025. doi:10.1016/j.ard.2025.10.013
BibTeX
@article{Assawasaksakul2025,
author = {Assawasaksakul, Theerada and Fava, Andrea and Goldman, Daniel and Magder, Laurence S and Petri, Michelle},
title = {25-Hydroxyvitamin D levels are associated with mortality and cardiovascular events in systemic lupus erythematosus},
journal = {Annals of the Rheumatic Diseases},
year = {2025},
doi = {10.1016/j.ard.2025.10.013}
}
EUVIMED